Agreed an additional contraceptive to the portfolio
a positive. The reason it is not Price Sensitive is
because it isn’t as reflected in SP. it is the fifth or
more Nuvaring included generic on market. The
sales numbers have actually increased but $ value
$400m lower . This used to be profit now consumer
savings. There is no more meat on the bone. Just
another product which may actually lose money in
scheme of things like other generics we are gradually
disposing.
- Forums
- ASX - By Stock
- Ann: FDA approval of HALOETTE, a generic version of NUVARING
MYX
mayne pharma group limited
Add to My Watchlist
3.27%
!
$5.03

Agreed an additional contraceptive to the portfolio a positive....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.03 |
Change
-0.170(3.27%) |
Mkt cap ! $408.6M |
Open | High | Low | Value | Volume |
$5.20 | $5.21 | $5.03 | $2.804M | 555.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14654 | $5.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.14 | 3111 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 5.010 |
2 | 61000 | 5.000 |
2 | 2200 | 4.990 |
2 | 702 | 4.970 |
3 | 2200 | 4.950 |
Price($) | Vol. | No. |
---|---|---|
5.140 | 3111 | 2 |
5.150 | 19052 | 1 |
5.180 | 396 | 1 |
5.200 | 2000 | 1 |
5.300 | 10000 | 1 |
Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |